Poll: Few consumers trust health orgs, pharma January 31, 2017By Karen AppoldA new report has troubling findings for payers, providers, and technology companies. Here are the key takeaways, and reactions from experts. Top 3 pharmacy challenges in 2017: Two-pronged solutionHere are three pharmacy challenges facing healthcare executives and a two-pronged solution to help solve them. Top challenges in cancer care January 14, 2017By Tracey WalkerCancer drug costs remain the most critical challenge in care, among other things. Watch list 2017: Top therapeutic areas January 03, 2017By Mari EdlinFind out about the latest treatment and drug pipeline developments Top pharmacy challenges of 2017 December 28, 2016By Mari EdlinHigh drug prices continue to plague payers, but various contributing factors intensify the problem. Will new autoimmune drugs address cost concerns? December 27, 2016By Erin Bastick PharmDFind out what’s in the drug pipeline for autoimmune disease. Top 2017 challenges healthcare executives face December 08, 2016By Karen AppoldResults from Managed Healthcare Executive’s annual State of the Industry Survey reveal which issues will hit managed healthcare hardest in 2017. Are payers optimistic about biosimilars’ savings? December 07, 2016By Erin BastickAs more biosimilars are approved, plans and PBMs will continue to evolve their strategies regarding coverage and formulary management of these new medications. Four innovative models rein in pharma costs December 05, 2016By Mari EdlinPlans and PBMs are finding new ways to rein in pharmacy costs. Hodgkin lymphoma: First hematologic cancer cured with immunotherapy? December 05, 2016By Bryant FurlowImmune checkpoint inhibitors are taking the stage in treating relapsed and refractory Hodgkin lymphoma. Read more.